Blood phenylalanine clearance and BH 4-responsiveness in classic phenylketonuria

Molecular Genetics and Metabolism

Volumn 103, Issue 4, 2011, Pages 399-400

  Bik Multanowski, Miroslaw ^a   Pietrzyk, Jacek J ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Dietary treatment; Inborn error of metabolism; PAH; Phenylalanine hydroxylase; Phenylalanine kinetics; PKU

Indexed keywords

PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TETRAHYDROBIOPTERIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG CLEARANCE; DRUG ELIMINATION; DRUG RESPONSE; ENZYME KINETICS; FEMALE; HUMAN; HUMAN TISSUE; HYDROXYLATION; HYPERPHENYLALANINEMIA; LOADING TEST; MALE; PHENYLKETONURIA; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; BIOPTERIN; CHILD; FEMALE; HUMANS; KINETICS; MALE; PHENYLALANINE; PHENYLKETONURIAS; YOUNG ADULT;

EID: 79960842692     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.04.014     Document Type: Article

References (5)

1. Muntau A.C., Röschinger W., Habich M., Demmelmair H., Hoffmann B., Sommerhoff C.P., Roscher A.A. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N. Engl. J. Med. 2002, 347:2122-2132.
2. Blau N., van Spronsen F., Levy H. Phenylketonuria. Lancet 2010, 376:1417-1427.
3. Kaufman S. A model of human phenylalanine metabolism in normal subjects and in phenylketonuric patients. Proc. Natl. Acad. Sci. 1999, 96:3160-3164.
4. Kalsner L.R., Rohr F.J., Strauss K.A., Korson M.S., Levy H.L. Tyrosine supplementation in phenylketonuria: diurnal blood tyrosine levels and presumptive brain influx of tyrosine and other large neutral amino acids. J. Pediatr. 2001, 139:421-427.
5. Levy H.L., Milanowski A., Chakrapani A., Cleary M., Lee P., Trefz F.K., Whitley C.B., Feillet F., Feigenbaum A.S., Bebchuk J.D., Christ-Schmidt H., Dorenbaum A. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin,6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet 2007, 370:504-510. Sapropterin Research Group.